Piper Jaffray Cuts Price Target on Anthera Pharma (ANTH) to $10 Following 4Q

March 11, 2016 8:31 AM

Piper Jaffray maintained an Overweight rating on Anthera Pharma (NASDAQ: ANTH), and cut the price target to $10.00 (from $14.00) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found